MedPath

Home-based Exercise in Chronic Kidney Disease

Not Applicable
Completed
Conditions
End-stage Renal Disease
Chronic Kidney Disease
Interventions
Other: Home-based exercise
Registration Number
NCT03621176
Lead Sponsor
Cardenal Herrera University
Brief Summary

A home-based exercise program will be implemented in three different groups of participants: advanced chronic kidney disease, end-stage renal disease in substitutive treatment hemodialysis or peritoneal dialysis. Participants will be evaluated before the program, after 3 months and after 6 months from the starting of the program. During the first 3 months the researcher will phone them weekly to reinforce the exercise habit, and during the last three months, there will be no reinforcement. Assessment will include strength, functional capacity, health-related quality of life and depressive symptoms.

Detailed Description

Three groups of participants (advanced chronic disease not yet in substitutive treatment, end-stage renal disease patients in hemodialysis and end-stage renal disease patients in peritoneal dialysis) will enter the study. The intervention will consist of a home-based exercise program. They will be provided with a booklet and the researcher will explain personally each of the exercises to the participants. Progression will be encouraged so that the participants should find the sessions 'somewhat hard' according to the rate of perceived exertion. Reinforcement will be high during the first 3 months (weekly phone calls, visits to the nephrology department) and none during the last 3 months. Assessment will be undertaken at three-time points: baseline, after 3 months of high reinforcement and after 3 more months of no reinforcement at all.

Assessment will include strength, functional capacity, health-related quality of life, cognitive state and depressive symptoms.

The aim of the study is to assess the effectiveness of home-based exercise to improve strength, physical function, health-related quality of life, cognitive state and depressive symptoms in advanced chronic kidney disease and end-stage renal disease (hemodialysis and peritoneal dialysis). We also aim at describing all these variables in the three different groups of patients. Adherence and satisfaction with the exercise program will be recorded at the end of the study.

Additionally, interobserver reliability will be calculated, so as reliability intraobserver in different measurement conditions (dialysis vs non-dialysis days).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
57
Inclusion Criteria
  • At least 3 months in hemodialysis treatment
  • Clinically stable
Exclusion Criteria
  • Recent cardiac events (less than 3 months)
  • Unable to exercise

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Home-based exerciseHome-based exerciseHome-based intervention in the advanced chronic kidney disease group, hemodialysis or peritoneal dialysis group
Primary Outcome Measures
NameTimeMethod
Change from baseline sit to stand 10 test at 12 and 24 weeksBaseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks

Sit to stand to sit test 10, time to perform 10 repetitions

Secondary Outcome Measures
NameTimeMethod
Change from baseline STS-60 at 12 and 24 weeksBaseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks

Sit to stand to sit test 60, number of repetitions performed during 60 seconds

Change from baseline SPPB at 12 and 24 weeksBaseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks

Short physical performance battery, a combination of walking speed, STS-5 and balance

Change from baseline TUG at 12 and 24 weeksBaseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks

Timed up and go test, time to stand up from a chair, walk 3m, turn around and sit back again

Change from baseline Handgrip strength (dynamometry) at 12 and 24 weeksBaseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks

Handgrip strength measured through a dynamometer

Change from baseline Six-minute walking test at 12 and 24 weeksBaseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks

Distance covered in 6 minutes

Change from baseline OLHR at 12 and 24 weeksBaseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks

One leg heel rise test, number of repetitions of heel rise to measure triceps strength

Change from baseline Health-related quality of life measured through the Euro quality of life questionnaire, 5 dimensions, at 12 and 24 weeksBaseline,12 weeks, 24 weeks

Euroquol 5D questionnaire, scale 0 (worst health) to 100 (best health). 5 Dimensions include mobility, personal care, activities of daily living, pain, and anxiety/depression

Change from baseline Beck depression inventory at 12 and 24 weeksBaseline,12 weeks, 24 weeks

Questionnaire to measure depressive symptoms. Range from 0 (normal) to 63 (worst depression)

Change from baseline OLST at 12 and 24 weeksBaseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks

One-leg stand test, time to keep the balance in one leg

Change from baseline Physical Activity Scale for the elderly at 12 and 24 weeksBaseline,12 weeks, 24 weeks

Questionnaire to measure physical activity. Higher scores represent higher activity.

Change from baseline Albumin at 12 and 24 weeksBaseline,12 weeks, 24 weeks

Serum albumin in blood for dialysis patients

Change from baseline Human activity profile at 12 and 24 weeks Human activity profileBaseline,12 weeks, 24 weeks

Questionnaire to measure physical activity. Higher score represents higher activity. Measures of average and maximal activity scores are reported. Average activity scores bellow 53 are considered impaired; between 53 and 74 are considered moderately active and above 74 are considered active.

Adherence12 weeks, 24 weeks

Sessions performed/offered x 100

Trial Locations

Locations (1)

Hospital de Terrassa

🇪🇸

Terrassa, Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath